P
The startup develops data-driven computational technologies that integrate multi-omics analysis with machine learning algorithms to identify clinically relevant genetic interactions in cancer patients. This approach provides actionable insights by ranking treatment options based on individual cancer vulnerabilities and treatment response factors.
Tel Aviv, Israel
Updated 2 months ago
Funding
$12M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops data-driven computational technologies that integrate multi-omics analysis with machine learning algorithms to identify clinically relevant genetic interactions in cancer patients. This approach provides actionable insights by ranking treatment options based on individual cancer vulnerabilities and treatment response factors.